Negative phase III trials announce the need for biomarkers in sarcoma

Alexander Tj Lee1, Paul H Huang2, Robin L Jones3

  • 1Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, UK.

European Journal of Cancer (Oxford, England : 1990)
|November 2, 2019
PubMed
Abstract

No abstract available in PubMed .